findmyKOL
Clinical trialNCT01121939CompletedPhase 2Interventional

Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers

SponsorSCRI Development Innovations, LLCEnrollment43Neuroendocrine Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Florida Hospital Cancer Institute

    Orlando, Florida, United States

  • Medical Oncology Associates of Augusta

    Augusta, Georgia, United States

  • Baptist Medical Center East

    Louisville, Kentucky, United States

  • Grand Rapids Oncology Program

    Grand Rapids, Michigan, United States

  • Research Medical Center

    Kansas City, Missouri, United States

  • Hematology-Oncology Associates of Northern Nj

    Morristown, New Jersey, United States

  • Oncology Hematology Care, Inc

    Cincinnati, Ohio, United States

  • Tennessee Oncology Associates

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2010
Primary completion
28 Feb 2015
Completion
31 Aug 2015
Last update posted
5 Feb 2016
Registered enrollment
43
Registry id
NCT01121939

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.